Astellas Pharma Inc (ALPMY)
9.50
+0.03
(+0.32%)
USD |
OTCM |
Apr 19, 16:06
Astellas Pharma Profit Margin (Quarterly): 3.44% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.44% |
| September 30, 2023 | -0.37% |
| June 30, 2023 | 8.83% |
| March 31, 2023 | -13.02% |
| December 31, 2022 | 12.04% |
| September 30, 2022 | 18.83% |
| June 30, 2022 | 6.50% |
| March 31, 2022 | -2.77% |
| December 31, 2021 | 17.87% |
| September 30, 2021 | 12.57% |
| June 30, 2021 | 9.41% |
| March 31, 2021 | -3.99% |
| December 31, 2020 | 18.46% |
| September 30, 2020 | 7.27% |
| June 30, 2020 | 16.42% |
| March 31, 2020 | 1.73% |
| December 31, 2019 | 18.19% |
| September 30, 2019 | 22.13% |
| June 30, 2019 | 17.51% |
| March 31, 2019 | 10.20% |
| December 31, 2018 | 24.49% |
| September 30, 2018 | 15.50% |
| June 30, 2018 | 16.58% |
| March 31, 2018 | 7.33% |
| December 31, 2017 | 16.82% |
| Date | Value |
|---|---|
| September 30, 2017 | 12.50% |
| June 30, 2017 | 13.17% |
| March 31, 2017 | 13.04% |
| December 31, 2016 | 18.01% |
| September 30, 2016 | 15.43% |
| June 30, 2016 | 19.72% |
| March 31, 2016 | 9.49% |
| December 31, 2015 | 16.29% |
| September 30, 2015 | 16.96% |
| June 30, 2015 | 12.98% |
| March 31, 2015 | 7.17% |
| December 31, 2014 | 12.49% |
| September 30, 2014 | 11.40% |
| June 30, 2014 | 12.15% |
| March 31, 2014 | 2.73% |
| December 31, 2013 | 11.69% |
| September 30, 2013 | 9.37% |
| June 30, 2013 | 7.36% |
| March 31, 2013 | 3.45% |
| December 31, 2012 | 9.78% |
| September 30, 2012 | 9.38% |
| June 30, 2012 | 14.59% |
| March 31, 2012 | -9.91% |
| December 31, 2011 | 16.89% |
| September 30, 2011 | 11.27% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.02%
Minimum
Mar 2023
22.13%
Maximum
Sep 2019
9.00%
Average
9.41%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Daiichi Sankyo Co Ltd | 14.89% |
| Takeda Pharmaceutical Co Ltd | 9.51% |
| Nxera Pharma Co Ltd | -2.85% |
| PeptiDream Inc | -8.20% |
| Stemcell Holdings Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.18% |
| Return on Assets | -0.09% |
| Return on Invested Capital | -0.14% |
| Gross Profit Margin (Quarterly) | 82.01% |
| Operating Margin (Quarterly) | 4.47% |
| Return on Net Operating Assets | -0.12% |